Atropos Health, a Palo Alto, CA-based chief in offering physicians with research-grade real-world proof on the level of care, closed a $14M Sequence A funding spherical.
The spherical was led by Breyer Capital with participation from Emerson Collective and Boston Millennia Companions. At the side of the funding, Emerson Collective’s Matt Bettonville and Breyer Capital can have seats on the Atropos Well being board of administrators.
The corporate will use the funds to increase its business group, additional construct on latest market traction, and proceed to develop its oncology product.
Led by newly appointed CEO Brigham Hyde, PhD, Atropos Well being is a developer of a doctor session service powered by research-grade real-world information. Utilizing thousands and thousands of anonymized affected person data, the corporate helps suppliers reply scientific questions which have fallen by means of the cracks of the evidence-based literature.
Current President, Neil Sanghavi, and Chief Medical Officer, Dr. Saurabh Gombar, will stay of their present roles. Co-founder Nigam Shah, MD/PhD, just lately appointed Chief Knowledge Scientist at Stanford College, will stay on the board.